Shows
The Biorevolution PodcastThe biorevolution podcast #36We are what we eat – The future of food
Food is a topic that is both deeply personal and of global importance. What we eat affects our health and longevity, but also the lives of animals and the future of our planet.
New technologies and scientific discoveries are now enabling us to transform how we produce food and personalize nutrition in entirely new ways.
In this episode, Andreas Horchler and Louise von Stechow speak with food expert and CEO of Berlin Food Campus, Lia Carlucci, about key trends shaping the future of food—from alternative proteins to personalized nutrition.
2025-07-0241 min
The Biorevolution PodcastThe biorevolution podcast #35New tech, new talent, new challenges – pharma leadership in the age of AI
Despite great hopes for Artificial Intelligence (AI) in biotech and pharma—with investments exceeding $50 billion over the past ten years—the question of when the technology will reach maturity remains difficult to answer. How can biotech and pharma leaders navigate this complex gray area, where hype around the technology obscures the outlook and few concrete milestones provide clear signposts for decision-making?
In this episode of the BioRevolution podcast, Louise von Stechow and Andreas Horchler speak with their guest, idalab founder Paul von Bünau, about t...2025-06-0241 min
The Biorevolution PodcastThe biorevolution podcast #34Illuminating the Dark Genome – New Insights into the Genetic Basis of Disease
More than 20 years after the Human Genome Project, enabled by new sequencing technologies, researchers are making progress in exploring the vast non-coding space that constitutes 98% of our genomes. This non-coding, or "dark," DNA harbors elements with important regulatory functions in health and disease. But pinpointing disease-relevant DNA elements within this massive DNA space can be like searching for a needle in a haystack. This difficult search can be eased by artificial intelligence (AI)-based tools, which predict the context-dependent relevance of certain DNA elements and highlight their ro...2025-05-0538 min
The Biorevolution PodcastThe biorevolution podcast #33The biochemistry of the mystical – a psychedelics renaissance?
When the Swiss chemist synthesized and tested the psychedelic compound LSD in the 1930s, he knew he had found a tool to explore the human mind.
Indeed, before psychedelics became illegal in the late 1960s, a mountain of evidence had been produced, showing potential benefits of psychedelic-assisted therapy for depression, anxiety, and substance abuse.
After a decades-long hiatus, research on psychedelics as a treatment for psychiatric diseases is experiencing a renaissance—and initial results look promising.
While the field has seen a setback with the recent request for more data by the...2025-04-0142 min
The Biorevolution PodcastThe biorevolution podcast #32A question of trust - Why we need science
This time on the BioRevolution podcast Andreas Horchler and Louise von Stechow discuss science itself.
While recent surveys show persistently high trust in science worldwide, certain scientific topics have become the subject of intense societal and political debate. This politicization of science puts scientists in a difficult position when they are trying to argue based on facts.
The value of facts and evidence-based science seems to be increasingly questioned by those in power and by those in control of assets. If those who make laws and...2025-03-0339 min
The Biorevolution PodcastThe biorevolution podcast #31More Boom or…Bust – What to expect from AI in biotech in 2025?
In some respects, 2024 has been a record year for AI in biotech, with the $1 billion founding of the antibody-centered biotech company Xaira and the awarding of the Nobel Prize in Chemistry to DeepMind researchers Demis Hassabis, John Jumper, and David Baker. However, despite years of investment and innovation, we still lack an answer to the most pressing question: Will AI revolutionize drug development, or are we in a bubble that is about to burst?
In episode 31 of the BioRevolution podcast, Andreas Horchler and Louise von Stec...2025-02-0339 min
The Biorevolution PodcastWe're doomed we're saved #30New year old me – no biohacks needed
2025: For millions of people, the new year starts with the self-promise to improve, to quit smoking, alcohol, to get in shape, to stay young and attractive, to basically create and become a new me. While traditionally new year vows meant to relinquish, today there seem to be many helpers in the form of biohacking.
Beginning with diets and not ending with technical devices.
While there are real shortcuts and fake abbreviations to reach some of those goals, there´s also traditional ways. In "New year old me – no biohacks needed", Louise von Stech...2025-01-0339 min
The Biorevolution PodcastWe're doomed we're saved #29The science of stress – a cortisol conspiracy
Modern humans are stressed creatures: overloaded schedules, constantly “on-call,” and social media haunting us into the late night.
Part of this stress is maladaptive responses that date back to human history when stressors were about life and death and not about writing emails and making phone calls. A key player in those ancient responses is cortisol, a stress hormone that interacts with many biological functions, from heart rate to glucose metabolism, to inflammation and immune responses, as well as sleep and cognition.
But is cortisol - as the social media proponents of the so...2024-12-0237 min
The Biorevolution PodcastWe're doomed we're saved #28Scientific Communication - Telling Stories that Matter
Science can be complex and difficult to grasp, yet public understanding is crucial for navigating issues like disease risk, climate change, and pandemics. Clear, engaging science communication can help prevent misinformation and conspiracy theories, offering facts in place of myths. But how can we make science more digestible and appealing?
Counterintuitively, it might be less facts and more emotions that can help to make science more appealing, more impactful – both when communicating to the public and to fellow scientists. In episode 28 of We’re doomed, We’re saved, Andreas Horchler and Louise von St...2024-11-0139 min
The Biorevolution PodcastWe're doomed we're saved #27AI in drug development – Expanding the option space
In the expensive and failure-prone process of drug development, artificial intelligence (AI) can serve both as an efficiency tool and as a creativity tool. Increased efficiency means shorter timelines, reduced investment, and earlier insights into success or failure. This can lead to more opportunities to bring new drugs to patients. Increased creativity means exploring new areas in drug discovery and development, such as identifying new patterns in targets, drug molecules, and patient populations that may be unintelligible to the human eye. While we are witnessing the first tangible milestones of AI in...2024-10-0131 min
The Biorevolution PodcastWe're doomed we're saved #26The future of medicine - trends, technologies and skills
How will the medicine of the future look? Healthcare and medicine are on the verge of transformative change, driven by new technologies such as artificial intelligence, telemedicine, and wearable devices. Alongside the technologization and virtualization of medicine, there is a shift from reactive approaches to preventative strategies and from one-size-fits-all treatments to personalized medicine.
In this future, human healthcare professionals and machines could work hand-in-hand to deliver the best possible care, with empowered patients acting as equal decision-makers who understand and access their own healthcare data. However, a darker scenario...2024-09-0230 min
The Biorevolution PodcastWe're doomed we're saved #251.5 years of LLMs - hope, hype and hallucination
Some 36 months after the release of ChatGPT, the verdict is still out on the role that large language models (LLMs) will play in biotech, pharma, and medicine. On paper, the range of tasks that LLMs can perform in biomedical research and healthcare is vast—excavating relevant information for drug discovery from mountains of scientific literature, designing novel proteins, transcribing doctors' notes, aiding diagnostic decision-making, and acting as patient-facing chatbots.
But given the models’ propensity to hallucinate, we need to define how much error we can tolerate for different LLM use cases in t...2024-08-0237 min
The Biorevolution PodcastWe're doomed we're saved #24Artificial intelligence - Hope for rare disease patients?
Rare or orphan diseases affect only a small percentage of the population and often lack effective treatments. While rare individually, in total, more than 350 million people worldwide live with rare diseases. Many of these are very hard to diagnose, let alone cure, and the rarity of patients challenges the development of novel treatments.
To make the development of drugs for rare diseases more efficient and successful, artificial intelligence (AI) could be an important ally not only for drug makers but also for patients.
In episode 24 of "We’re...2024-07-0231 min
The Biorevolution PodcastWe're doomed we're saved #23New biotechnologies - Revolution or evolution?
When we think about revolutions, we think of systemic changes in politics, economics, and lifestyles. Revolutions transform how we live, work, interact, and communicate. In the past, political uprisings and new technologies, from the steam engine to the smartphone, have led to such transformative changes.
Now, a revolution driven by novel biotechnologies (gene editing, neuroprosthetics, synthetic biology, and artificial intelligence in biotech) has the potential to not only change the way we live but the very foundations of our lives – our biology.
But is the so-called biorevolution a real "sc...2024-06-0342 min
The Biorevolution PodcastWe're doomed we're saved #22Polygenic risk scores – The Truth in our Genes
Polygenic risk scores (PRS), put simply, look at gene variants across the human genome in order to determine an individual's risk of getting a disease, from different types of cancer to type II diabetes. PRS could complement current risk prediction models and lead to a more accurate risk prediction. However, for PRS to become a useful clinical instrument, transparent ways to assess their performance and careful communication of disease risks to individuals are key.
In episode 22 of We’re doomed we’re saved, Andreas Horchler and Louise von Stechow speak to two PR...2024-05-0341 min
The Biorevolution PodcastWe're doomed we're saved #21Cell rejuvenation – Resetting the biological clock
Aging is a dynamic process characterized by the accumulation of cell damage, tissue, and organ degeneration, and diminished function. This process of decline appears to be an inevitable aspect of human existence. In recent years, however, advancements in scientific understanding of aging bring us closer to extending the human lifespan.
With their guests, Dr. Jürgen Reess and Prof. Hartmut Geiger, founders of Moglingbio, Louise von Stechow and Andreas Horchler explore the complex science underlying the process of aging and the challenges faced by the budding longevity industry. They talk about the potential for...2024-04-0343 min
The Biorevolution PodcastWe're doomed we're saved #20Women’s Health - Humanity’s other half
Women make up about half of humanity. Yet, the medical community and the pharmaceutical and biotech industries have long adopted an androcentric view of disease biology and healthcare needs, perceiving women as a specialized or atypical demographic.
In episode 20 of We're Doomed, We're Saved, we talk to two biotech experts, Catenion's Dr. Ana Rita Da Costa and Dr. Pascal Joly, to discuss how the biotech industry and healthcare community slowly, but steadily, change and adapt to the needs of half of their customers: women.
Content and Editing:
Louise von Stec...2024-03-0437 min
The Biorevolution PodcastWe're doomed we're saved #19mRNA Therapeutics - New applications for an old molecule
RNA, one of the oldest and most versatile biomolecules, has recently entered the therapeutic arena. While for many observers the success of mRNA vaccines seemed to come out of the blue, its build on the fundament of research that has large gone ignored.
Now mRNA therapeutics are enjoying the limelight of great economic success for companies like BioNTech / Pfizer and Moderna, and the awarding of the 2023 Nobel Prize to two mRNA researchers. But with the fame also comes a huge public backlash of anti-vaxxers who fear the perceived novelty of...2024-02-0141 min
The Biorevolution PodcastWe're doomed we're saved #18Ozempic & co – A new era of weight loss?
In principle the solution to the problem of overweight should be very easy:
eat less and exercise more.But anyone who’s ever tried to lose weight – so probably almost anyone – will be able to testify that things are not as simple. So now Ozempic enters the scene, a diabetes drug that looks like a gamechanger in the big business of weight loss.
In episode 18 of We're doomed we're saved, Andreas Horchler and Louise von Stechow discuss the history of weight loss pills and the medical and cultural reasons why we (think we...2024-01-0234 min
The Biorevolution PodcastWe're doomed we're saved #17CRISPR CAS – Life’s processing tool
Gene editing technology allows humans, for the first time, to change the code of life with a precise editing system offering the potential for curing genetic diseases. The gene editing field is moving with impressive speed: after the seminal paper on the technology was published in 2012, the Nobel Prize awarded for the technology in 2020, and the first therapy approved for treatment of blood diseases in 2023.
In this episode of We’re doomed, we’re saved Andreas Horchler and Louise von Stechow, discuss the tremendous potential of the technology, but also its darker side – the high c...2023-12-0141 min
The Biorevolution PodcastWe're doomed we're saved #16Synthetic Biology - Rewriting Life
Synthetic biology - the artificial creation of biological molecules, cells, and even organisms - has the potential to revolutionize biotechnology and agriculture, allowing for the creation of novel biomaterials and fuels, opening new opportunities for DNA-based information storage and computation, and even aiding in the exploration and colonization of space. The first synthetic bacterium was created about ten years ago, and since then, the technologies supporting synthetic biology have become faster, cheaper, and more innovative. With the assistance of artificial intelligence, synthetic biology could unlock vast potential, recognized by various industries. Synthetic biology could...2023-11-0140 min
The Biorevolution PodcastWe're doomed we're saved #15Big data in pharma - From garbage to gold
In our data-heavy age, data becomes a treasure, a currency, a valuable good. This is true especially for the biotech and pharmaceutical industries, where data can inform the development of novel drugs. But should own biomedical data – and where should the lines between privacy and patient benefit be drawn?
In the new episode of We’re doomed, we’re saved, Andreas Horchler and Louise von Stechow discuss new strategies of data sharing and ownership in biomedicine and pharma.
Content and Editing:
Louise von Stechow and Andreas Horchler
Disc...2023-10-0233 min
The Biorevolution PodcastWe're doomed we're saved #14De-extinction - A mammoth project
The rapid spread of humans is causing many species to disappear off the face of the earth – in a so-called mass extinction. Some scientists are trying to reverse this process, by bringing back extinct species, such as the Dodo, the Passenger Pigeon, or the Wolly Mammoth.
In the 14th episode of We’re doomed, we’re saved Andreas Horchler and Louise von Stechow discuss the breeding procedures and genetic engineering techniques that might be used for brining back extinct animals. We also discuss the ethical implications from resource waste to animal welfare – and what it might...2023-09-0435 min
The Biorevolution PodcastWe're doomed we're saved #13365 days We're doomed we're saved
**** GERMAN EPISODE ****
Ein Jahr We're doomed we're saved - seiten einem Jahr sprechen Andreas Horchler und Louise von Stechow über die Themen der Biorevolution. Wir haben über Anitbiotikaresistenzen, Biowaffen, Gentherapien, Neuroprothesen und AI gesprochen. Wir hatten spannende Gäste, wie den Mathematiker und idalab Gründer Paul von Bünau, und den Forschungs- und Entwicklungschef von Sanofi Adventis Deutschland mit denen wir über die Rolle neuer Technologien wie AI für die Medikamentenentwicklung gesprochen haben.
In dieser Folge lassen wir die erste Staffel Revue passieren und machen "A big announcment". Dies wird unsere vorerst letzte...2023-08-0225 min
The Biorevolution PodcastWe're doomed we're saved #12Follow the money - Die Geldquellen der Biowissenschaften
**** GERMAN EPISODE ****
Follow the money, folge dem Geld, ist eine alte Weisheit wenn man den Kern einer Angelegenheit verstehen will.
In der 12. Folge von We're doomed we're saved folgen wir diesem Weg zu den Geldquellen der Biomedizinischen Forschung, zu Regierungszuschüssen, großen Pharmaunternehmen und privaten Stiftungen, wie der Bill und Melinda Gates Foundation, die ganze Forschungszweige quasi im Alleingang finanziert. Solche privaten Geldgeber haben besonders in den USA einen großen Einfluss auf die Forschungslandschaft, obwohl ihre Auswahlkriterien und Transparenz umstritten sind und die Verbindung von Wissenschaftlern und reichen Technokraten das...2023-07-0333 min
The Biorevolution PodcastWe're doomed we're saved #11Die Zukunft der Pharmaindustrie - Neue Technologien und Modelle
**** GERMAN EPISODE ****
Wie werden neue Technologien, wie die künstliche Intelligenz die Pharmaindustrie beeinflussen? Welche neuen Modelle werden die Blockbuster der Vergangenheit ablösen?
In dieser Folge sprechen wir mit unserem Gast Professor Jochen Maas, Geschäftsführer Forschung & Entwicklung Sanofi-Aventis, Deutschland GMBH über die Zukunft der Pharmaindustrie
Content and Editing:
Louise von Stechow and Andreas Horchler
Disclaimer:
Louise von Stechow, Andreas Horchler and their guests express their personal opinions, which are founded on research on the respective topics, but do not claim to give medical, inves...2023-06-0139 min
The Biorevolution PodcastWe're doomed we're saved #10Biohackers - Die Garagenwissenschaftler
**** GERMAN EPISODE ****
Biohacker experimentieren an sich selbst, führen genetische Modifikationen durch, implantieren Mikrochips und testen neue Medikamente. Dabei bewegen sie die Wissenschaft aus den Elfenbeintürmen der Universitäten hin zu privaten Laboren, Küchen und Garagen. Dies verspricht größere Chancengleichheit und neue Möglichkeiten für Innovationen in der Wissenschaft, birgt jedoch auch die Gefahr einer mangelnden Regulierung mit unvorhersehbaren Konsequenzen.
In der neuen Folge von We’re doomed we’re saved besprechen Andreas Horchler und Louise von Stechow die Ziele und Methoden der Biohacker und stellen die Frage ob sie eine Chance ohne...2023-05-0238 min
The Biorevolution PodcastWe're doomed we're saved #9ChatGPT - The rise of the chatbots
**** GERMAN EPISODE ****
ChatGPT, das Large Language Model von OpenAI ist in aller Munde. Von Untergangsszenarien in denen der Mensch und seine Arbeitsleistung als obsolet erklärt werden, über Lehrende, die sich fragen, wie sie Seminararbeiten bewerten sollen, bis hin zur Frage menschlicher und maschineller Kreativität – ChatGPT bewegt uns alle.
In der neuen Folge von We’re doomed we’re saved besprechen Louise von Stechow und Andreas Horchler welche Auswirkungen ChatGPT und andere Large Language Modelle für den Gesundheit Sektor und die Biotech und Pharma Industrie haben könnten und ob sie...2023-04-0338 min
Der Moment der Wahrheit: Innehalten. Verstehen. Umdenken.Der Moment der Wahrheit mit Louise von Stechow, Zellbiologin und Wissenschaftskommunikatorin für BiorevolutionInnehalten Verstehen Umdenken
Louise von Stechow betreibt Wissenschaftskommunikation aus verschiedenen Blickwinkeln. Im Moment der Wahrheit schaut sie mit uns in die Zukunft, was die Biorevolution mit uns - den Menschen - macht. Als promovierte Zell- und Molekularbiologin, Autorin und Beraterin für Pharma-, Bio- und MedTech-Unternehmen erklärt und klärt sie auf über die grundlegenden Zusammenhänge von Technologie und Biologie. Dabei schaut sie nicht nur nach dem technisch Machbaren, sondern hinterfragt kritisch. Bezieht ethische Aspekte und Gerechtigkeit in ihre Vorstellungswelt mit ein. Gibt Orientierung, ohne die neuen Technologien zu verdammen.
“we’re doomed, we’re saved” http...2023-03-161h 13
The Biorevolution PodcastWe're doomed we're saved #8Longevity- Who wants to live forever?
GERMAN EPISODE
Seit Anbeginn der Menschheit beschäftigt uns die Frage, warum wir altern, warum wir sterben müssen. In der neuen Folge von We’re doomed, we’re saved besprechen Andreas Horchler und Louise von Stechow den neuesten biomedizinische Forschungstand zum Thema Altern und stellen die Frage ob sich das Altern verlangsamen, ja sogar aufhalten lassen wird? Wie sähe eine Welt aus, in der die Menschen 150 Jahre oder noch älter werden – was würde ein verlängertes Leben für die Art wie wir leben, lieben und arbeiten, für die Dinge, die uns...2023-03-0134 min
The Biorevolution PodcastWe're doomed we're saved #7Künstliche Intelligenz – Der vorhersagbare Mensch
GERMAN EPISODE
Künstliche Intelligenz könnte dabei helfen, Krankheiten zu erkennen und zu heilen, Ärzten eine schnellere oder genauere Diagnose ermöglichen, und den Prozess der Arzneimittelentwicklung effizienter, kostengünstiger und erfolgreicher machen.
Gleichzeitig wirft die Verwendung von Künstlicher Intelligenz im medizinischen Bereich schwierige ethische Fragen auf. Algorithmen, die Parameter wie elektronische Patientenakten, genetische Analysen oder Marker psychiatrischer Erkrankungen zur Vorhersage menschlicher Gesundheit nutzen könnten inhärente Bias kodieren und für unethische Fragestellungen verwendet werden.
In Folge 7 von We’re doomed, we’re saved besprechen Louise von Stechow und Andreas Horchler...2023-02-0143 min
The Biorevolution PodcastWe're doomed we're saved #6Neuroprosthetics - Das Zeitalter der Cyborgs
GERMAN EPISODE
Prothesen, die mit dem Nervensystem verbundenen werden, können Menschen mit Einschränkungen helfen verlorene Mobilität und Sensorik zurückzuerlangen. Exoskelette und robotische Körperteile helfen Querschnittsgelähmten beim Gehen und Greifen. Cochleaimplantate und bionische Augen geben Tauben und Blinden ihre Sinne zurück. Hirn-Computer-Schnittstellen ermöglichen es Gehirnaktivitäten zu messen, zu interpretieren, und Gedanken in Befehle umzuwandeln, die von externen Geräten ausgeführt werden.
Doch ist das schon das Ende? Technologische Neurungen in der Neuroprothetik und künstliche Intelligenz könnten es uns schon bald erlauben unsere Sinne und Geh...2023-01-0535 min
The Biorevolution PodcastWe're doomed we're saved #5Biowaffen - Neue Möglichkeiten und alte Ängste
GERMAN EPISODE
Biowaffen haben zum Glück in der Geschichte der Menschheit nur selten Anwendung gefunden – sind sie doch zu unkontrollierbar. Doch mit den Technologien der Biorevolution eröffnen sich neue Möglichkeiten in der Herstellung schädlicher biologischer Agenzien – mit böser Intention von Staaten, Terroristen und sogenannten Biohackern, doch auch wohlmeinenden und unbedachten Wissenschaftlern. In dieser Folge sprechen Andreas Horchler und Louise von Stechow über die Geschichte der Biowaffen, über neue Möglichkeiten und alte Ängste.
Content and Editing:
Louise von Stechow and Andreas Horchler
Disclaimer:
Lo...2022-12-0231 min
The Biorevolution PodcastWe're doomed we're saved #4Gene drives - Menschengemachte Evolution
GERMAN EPISODE
Sogenannte Gene Drives sind spezielle Genveränderungsmethoden, die es Wissenschaftlern zum ersten Mal erlauben die Grenzen der klassischen Evolution nach Darwin zu sprengen und ihr Grundprinzip, die natürliche Selektion zu überwinden, in dem sie die Expression in allen Nachkommen erzwingen. In dieser Episode unterhalten sich Andreas Horchler und Louise von Stechow darüber wie Gene Drives in der Malariaprävention, in der Bewahrung bedrohter Arten und zur Erhöhung von Ernteerträgen eingesetzt werden könnten – und wie gefährlich diese Technologie in der Hand eines einzelnen Wissenschaftlers sein kann.
Content a...2022-11-0341 min
The Biorevolution PodcastWe're doomed we're saved #3Editiertes Erbgut - Reparaturen und Upgrades
GERMAN EPISODE
Gentherapien und Geneditierungsverfahren versprechen die Heilung von Krankheiten von Hämophilie bis Krebs. Sie erlauben aber auch genetische Upgrades – die uns schneller, schlauer und schöner machen könnten. In dieser Folge unterhalten sich Andreas Horchler und Louise von Stechow über die Möglichkeiten die Gentherapien und die neuentdeckte Technologie CRISPR-Cas bieten, welche klinischen Erfolge erzielt wurden und welche ethischen Konsequenzen diese Methoden mit sich bringen.
Content and Editing:
Louise von Stechow and Andreas Horchler
Disclaimer:
Louise von Stechow, Andreas Horchler and their guests express their personal opinion...2022-10-0437 min
The Biorevolution PodcastWe're doomed we're saved #2Endliche Antibiotika - Die vertane Chance
GERMAN EPISODE
Antibiotika wurden einst als Heilbringer der Menschheit gefeiert und haben dazu beigetragen die durchschnittliche Lebenserwartung stark zu erhöhen. Doch schon in den frühen Tagen warnte der Finder des Penicillins, Sir Alexander Fleming, vor dem unbedachten und verschwenderischen Umgang mit diesen Wundermedikamenten. In dieser Folge beleuchten Andreas Horchler und Louise von Stechow die weltweite Gesundheitskrise, die von antibiotikaresistenten Bakterien hervorgerufen wird und besprechen ihre Ursachen und potentielle Gegenmaßnahmen.
Content and Editing:
Louise von Stechow and Andreas Horchler
Disclaimer:
Louise von Stechow, Andreas Horchler and their gue...2022-09-0134 min
The Biorevolution PodcastWe're doomed we're saved #1Die Biorevolution - Risiken und Versprechen
GERMAN EPISODE
Die Biorevolution bringt viele neue Technologien, mit großen Versprechungen, aber auch unkalkulierbaren Risiken. In dieser Folge geben Andreas Horchler und Louise von Stechow einen Überblick über die Technologien der Biorevolution und sprechen über die Möglichkeit den Menschen selbst, seine Gene und sein Gehirn zu revolutionieren und über die Unmöglichkeit biologische Agenzien zu kontrollieren, die sich nicht um menschengemachte Regeln, Grenzen und ethische Bedenken kümmern.
Erscheint montatlich am 1.
Content and Editing:
Louise von Stechow and Andreas Horchler
Disclaimer:
Louise von Stechow, Andreas Horchler and their gu...2022-08-0440 min